NCT03016390

Brief Summary

Cardiovascular Implantable Electronic device (CIED) is a evolution therapy and number of patients with it are growing rapidly. Electromagnetic interference causing device malfunction is not uncommon, Radiofrequency Identification system is among its plausible source. Patients with CIEDs are at risk of exposure to this novel product in their daily living especially automobile keyless access system. Only informal studies have been conducted and not be published. Formal and systemic evaluation and tests are crucial.

Trial Health

50
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 10, 2017

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
Last Updated

January 10, 2017

Status Verified

January 1, 2017

Enrollment Period

1 year

First QC Date

January 9, 2017

Last Update Submit

January 9, 2017

Conditions

Keywords

Cardiac Implantable Electronic DevicePacemakerAutomatic Implantable Cardioverter-Defibrillator (AICD)Electromagnetic interference (EMI)Keyless access systemKeyless entry system

Outcome Measures

Primary Outcomes (1)

  • Incidence of any Electromagnetic interference

    Immediately after completion of the protocol test

Secondary Outcomes (3)

  • Incidence of pacing inhibition in ventricular channel

    Immediately after completion of the protocol test

  • Incidence of noise reversion

    Immediately after completion of the protocol test

  • Incidence of ventricular tachycardia/fibrillation detection

    Immediately after completion of the protocol test

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients participated at our Cardiac Rhythm Device Management (CRDM) clinic at Maharaj Nakorn Chiang Mai hospital, Faculty of medicine, Chiang Mai University will be invited. And at least 100 consecutive patients to be equally enrolled in both pacemakers(including single chamber, dual chamber and Cardiac Resynchronization Therapy pacemaker-CRTP) and Automatic Implantable Cardioverter-Defibrillator (AICD) (including single chamber, dual chamber and Bi-ventricular AICD or CRTD)

You may qualify if:

  • Age more than 18 years old
  • Able to give informed consent
  • Implanted with functioning pacemakers or AICD more than 3 months
  • Adequate and stable all device parameters
  • Able to operate self triggering event recorders (at least 30 seconds)

You may not qualify if:

  • Patient with single chamber (Atrial) pacemaker (AAI or AAIR)
  • Presence of unstable hemodynamic or conditions
  • Presence of sustained or ongoing arrhythmia, besides atrial fibrillation/atrial flutter in single (ventricle) chamber device or Atrio-ventricular block
  • Documented of over-sensing episodes under regular sensitivity threshold (0.25 mV or more in the atrial channel and 0.75 mV or more in the ventricular channel, for permanent pacemaker device, and manufacture default setting in Automatic Implantable Cardioverter-Defibrillator, AICD)
  • Lack of noise oversensing detection/trigger and Electrogram (EGM) storage capability
  • Lack of tachyarrhythmia detection and episode storage capability

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Prasertwitayakij N, Komolmis T, Gunaparn S, Pisespongsa C, Phrommintikul A, Wongcharoen W, Nantsupawat T. Electromagnetic interference from automobile passive keyless entry in cardiovascular implantable electronic devices. Expert Rev Med Devices. 2023 Jul-Dec;20(11):973-977. doi: 10.1080/17434440.2023.2255126. Epub 2023 Sep 5.

Study Officials

  • Arintaya Phrommintikul, MD

    Faculty of Medicine, Chiang Mai University

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CROSSOVER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

January 9, 2017

First Posted

January 10, 2017

Study Start

April 1, 2016

Primary Completion

April 1, 2017

Last Updated

January 10, 2017

Record last verified: 2017-01